Ridgefield, CT, United States of America

Jennifer D Hamilton

This inventor holds 15 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Allergy Treatment. Top assignees: Sanofi Biotechnology, Regeneron Pharmaceuticals, Inc.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer D Hamilton. Retrieved from https://idiyas.com/inventor/jennifer-d-hamilton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 93.3

 

 

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 81(Granted Patents)


Location History:

  • Hopewell Junction, NY (US) (2017 - 2023)
  • Ridgefield, CT (US) (2021 - 2024)

Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Allergy
Immunotherapy
IL-4R Antagonist
Chronic Rhinosinusitis
Asthma
Eosinophilic Esophagitis
COVID-19
Nasal Polyps
Skin Infection
Gene Expression
Antibody
Cat Allergy
15 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jennifer D Hamilton

Introduction

Jennifer D Hamilton is a prominent inventor based in Ridgefield, CT (US). She has made significant contributions to the field of medical science, particularly in the development of treatments for viral infections and respiratory conditions. With a total of 10 patents to her name, Hamilton's work has the potential to impact public health significantly.

Latest Patents

Hamilton's latest patents include groundbreaking methods for treating or preventing SARS-CoV-2 infections and COVID-19. This invention provides methods for preventing and treating these infections through the administration of antigen-binding molecules, such as antibodies that target the spike protein of SARS-CoV-2. Another notable patent focuses on treating or preventing asthma by administering an IL-4R antagonist. This method involves therapeutic compositions that include an interleukin-4 receptor antagonist, such as an anti-IL-4R antibody, aimed at alleviating asthma symptoms in patients.

Career Highlights

Throughout her career, Hamilton has worked with leading companies in the biotechnology sector, including Regeneron Pharmaceuticals, Inc. and Sanofi Biotechnology. Her experience in these organizations has allowed her to develop innovative solutions that address critical health challenges.

Collaborations

Hamilton has collaborated with notable professionals in her field, including Allen Radin and Marius Ardeleanu. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Jennifer D Hamilton's contributions to medical science through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for innovative treatments that can improve health outcomes for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…